Why Does Benzodiazepine Withdrawal Cause Itching, Rashes, and Other Allergy-like Symptoms, and Is Histamine to Blame?

Are allergy-like symptoms really part of benzodiazepine withdrawal?

Is the itching real? Are the rashes, the flushing, and the new reactions to familiar foods really coming from the taper? Yes, and the Ashton Manual says so. In Chapter III, Table 1, under physical symptoms, Professor C. Heather Ashton lists skin rashes and itching, and the same chapter describes an apparent intolerance to certain foods in patients with protracted symptoms, even though reliable tests for true food allergy are nearly always negative.

Many readers arrive here after searching for “histamine bursts,” a phrase that circulates in patient forums but is not a medical term. It describes allergy-like symptoms in a person whose nervous system is recalibrating after months or years on a drug that quieted it. The symptoms are real. The label is borrowed.

A patient who took a benzodiazepine as prescribed and now cannot stop without symptoms has physical dependence, a medical condition caused by the medication, and physical dependence is not addiction. The right response is a slow, medically supervised taper rather than an addiction program, and the skin and food symptoms in this article are managed inside that taper.

The Ashton Manual recognizes skin rashes, itching, and apparent food intolerance.

The Manual is careful with its claims, and so is this article. Table 1 also lists flushing beside sweating and palpitations, and its skin entries sit beside the burning sensations covered in the post on burning skin sensations in benzodiazepine withdrawal. It does not list hives, and it never mentions anaphylaxis.

Professor Ashton places the apparent food intolerances among the protracted gastrointestinal symptoms of Chapter III, adds that benzodiazepine use and withdrawal may affect immune responses, and says plainly that it is not clear whether the infections patients complain of truly increase.

In Dr. Mark Leeds’ practice the pattern patients describe is broader still. Itching with nothing to see, hot flushing of the face and chest, red blotches that come and go within an hour, welts after a meal that never caused trouble before, and a nose that runs at odd hours are common reports. None of these prove an allergy, and most of them rise and fall with the waves of withdrawal, which is the first clue that the immune system is not the whole story.

Is histamine really to blame?

Histamine is a chemical that immune cells called mast cells release during an allergic reaction. It widens blood vessels, makes skin itch and swell, and sets the nose running, which is why an antihistamine tablet eases hay fever.

So, could a nervous system in withdrawal be releasing histamine? It is plausible. Benzodiazepines boost gamma-aminobutyric acid (GABA), the brain’s main calming signal, and when the drug is reduced the whole system runs hot for a while. The Manual itself notes in Chapter III that chronic overbreathing, which is common in patients who are anxious or in withdrawal, may release histamine and produce “pseudo-allergic” reactions and food intolerance.

Yet, plausible is not proven. No reliable measurement has shown a surge of histamine during a taper, the evidence on the mechanism is limited, and the honest description is clinical experience, which varies. Dr. Leeds treats histamine as a useful working idea rather than a diagnosis, and he manages the symptom rather than the theory.

Think of a smoke alarm set far too sensitive. It shrieks at burnt toast, at nothing at all, and the house is not on fire. In withdrawal the skin and gut are wired to an alarm like that, and the task is to let the sensitivity settle slowly, not to rip the alarm off the wall by stopping the drug. The next question is how to tell burnt toast from a real fire.

How does a person tell withdrawal itching from a true allergic reaction?

This is the question that matters most, because getting it wrong in one direction is dangerous. Withdrawal-related skin symptoms itch, prickle, or flush, they wander around the body, and they come and go in waves without swelling of the lips, tongue, or throat and without trouble breathing. They are miserable, and they are not an emergency.

A true allergic reaction looks different, and anaphylaxis is never a withdrawal symptom. It is a medical emergency that must never be blamed on the taper and never waited out. Call 911 if any of the following appear:

• Swelling of the face, lips, tongue, or throat, or a feeling that the throat is closing.
• Trouble breathing, wheezing, or a hoarse or tight voice.
• Hives spreading quickly over the body together with dizziness, faintness, or a racing heart.
• Sudden vomiting or cramping that arrives with any of the signs above.

A new medication or supplement started during a taper can cause a real allergy, so a rash that follows a new pill is worth a same-day call to the prescriber.

The 2020 United States Food and Drug Administration (FDA) boxed-warning update says that stopping a benzodiazepine abruptly can cause seizures that may be life-threatening, so call emergency services for a seizure or any medical emergency. And, if the strain of withdrawal ever brings thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline, or call 911.

What helps with the itching and the food reactions while the taper continues?

Fortunately, most of the useful measures are plain. A simple diary of meals, symptoms, and the time of day, kept for a few weeks, identifies trigger foods far better than memory does, and usually only a handful of foods are involved. Cutting out whole food groups on the strength of an internet list tends to leave a person underfed and no less itchy, so the sensible course, and the Manual’s, is to remove only what the diary convicts, one item at a time, and to talk it through with the prescriber.

Antihistamines are a conversation with the prescriber, not a solo decision. The Manual mentions a sedating antihistamine as a short-term option for sleep in Chapter III, and a non-drowsy antihistamine may take the edge off daytime itching, yet even the non-drowsy kind can add some sedation on top of a benzodiazepine and blur how a dose reduction feels. The prescriber needs to know before, not after.

Supplements sold for “histamine intolerance” and mast cell problems are another matter. The evidence for them in benzodiazepine withdrawal is thin, and a nervous system this sensitive reacts to new substances unpredictably, so a shopping cart of capsules started on a forum’s advice often makes a wave worse, and any supplement belongs in a conversation with a physician who understands the pharmacology. Cool showers, fragrance-free moisturizer, loose cotton, short fingernails, and slow breathing through the nose, which counters the overbreathing the Manual links, with some evidence, to histamine release, are boring, and they help.

Do these symptoms ease as the taper goes on?

For most patients, in Dr. Leeds’ experience, yes, and the pace of the taper is the treatment. The Chapter II schedules in the Ashton Manual reduce the dose in small steps, each a small fraction of the current dose, held until the patient feels steady, and the Maudsley Deprescribing Guidelines refine that shape with hyperbolic reductions, meaning the steps grow smaller as the dose gets lower. Where a short-acting drug makes symptoms swing between doses, a crossover taper to diazepam, as the Manual describes, can smooth the ride.

A wave of itching or flushing is a signal to hold the dose, not to push through and not to jump off. The Manual’s one exception to slow reduction is triazolam, a very short-acting drug it says can be stopped abruptly, and even there Dr. Leeds prefers a gradual taper, consistent with the FDA’s 2020 advice that no standard schedule suits every patient. Abrupt stopping is never recommended.

The bound is time. Allergy-like symptoms tend to fade as the dose comes down and after the last dose, and a taper planned to avoid a rushed finish gives the skin the same slow settling as the nervous system. The post on benzodiazepine deprescribing designed to avoid protracted withdrawal explains how that plan is built, and once the alarm has settled, the skin is usually the last thing a patient thinks about.

Dr. Leeds manages allergy-like symptoms inside the taper, not apart from it.

Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. His practice offers medically supervised benzodiazepine and z-drug tapering, built on the Ashton Manual and adapted to each patient over months, sometimes longer. He works directly with every patient, with no team and no clinic staff between them, as a concierge practice that does not bill insurance, and he prescribes for patients in Florida only.

When a patient reports itching, flushing, or food reactions, the response is the same as for any other withdrawal symptom: rule out a true allergy, slow or hold the taper, and keep the patient in charge of the pace. Informed consent in his practice means risks first, alternatives including staying at the current dose, an exit plan from day one, and the right to decline any step without any change in how the patient is treated.

An itchy, flushing, reactive body in withdrawal is frightening, and it is usually a sensitive alarm rather than a fire. Dr. Leeds’ practice helps patients in Florida tell the two apart and taper at a pace their skin, gut, and nervous system can tolerate. Contact Dr. Leeds to ask about a medically supervised taper.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.